Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART



Status:Completed
Conditions:Infectious Disease, HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:16 - 24
Updated:3/29/2019
Start Date:October 2012
End Date:June 2016

Use our guide to learn which trials are right for you!

A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D3 50,000 IU Every 4 Weeks to Increase Bone Mineral Density and Decrease Tenofovir-Induced Hyperparathyroidism in Youth With HIV Infection Being Treated With Tenofovir-Containing Combination Antiretroviral Therapy (cART)

This is a 48 week randomized double-blind, placebo-controlled prospective cohort study of
adolescents and young adults with HIV infection in the Adolescent Medicine Trials Network for
HIV/AIDS Interventions (ATN) who are currently being treated with cART that includes
tenofovir disoproxil fumarate (TDF) as one component of the regimen that includes at least
three Food and Drug Administration (FDA)-approved antiretroviral (ARV) drugs for at least 180
days.

This is a 48 week randomized double-blind, placebo-controlled prospective cohort study of
adolescents and young adults with HIV infection in the ATN who are currently being treated
with cART that includes TDF as one component of the regimen that includes at least three Food
and Drug Administration (FDA)-approved ARVs for at least 180 days. Subjects must have at
least one documented viral load that is below 200 copies/mL that is collected following
initiation of TDF containing cART and greater than 90 days prior to randomization; no viral
load above 200 copies/mL if measured within the 90 days prior to randomization; and an HIV
viral load obtained at screening that is below 200 copies/mL.

Treatment assignments will be balanced by subject sex at birth, age (<20 years vs. >=20
years), and race (African American vs. other). Enrolled subjects will be randomized to
receive vitamin D3 50000 IU or matching placebo, given orally every four weeks by DOT. In
addition to the randomized study agent, all subjects will receive a MVI to be taken orally
once daily. This "standard" MVI will contain ingredients not to exceed 600 IU of vitamin D3
and 200 mg Ca.

Dual energy x-ray absorptiometry (DXA) measurement of bone mineral content (BMC)/bone mineral
density (BMD) of whole body, spine, and hip, will be performed at baseline and study weeks 24
and 48. Blood and urine sampling to assess the Ca-phosphorous (PO4) axis, parathyroid hormone
(PTH)-FGF23-vitamin D signaling, bone turnover, and renal glomerular and tubular function
will occur at baseline and study weeks 12, 24, and 48. Blood samples to measure Gluc
homeostasis will be drawn at baseline and week 48, and will be run by batch analysis.

Safety, measured by serum calcium (SCa) and serum creatinine (SCr), will be monitored by
subject's record review at study sites since these labs will generally be measured as a part
of routine clinical care. The Adolescent Medicine Trials Network for HIV/AIDS Interventions
109 (ATN 109) study will use the SCa and SCr values obtained within 10 weeks at the time of
the visit beginning at the baseline visit. If these evaluations were not performed within the
prior 10 weeks they will be drawn at the time of each visit. Viral load and cluster of
differentiation 4 (CD4) cell count results will be recorded for this study, ATN 109, at
screening, baseline and study weeks 12, 24, 48, and Post-Week 48 provided the evaluations
were done within the protocol specified timeframe. If the evaluations were not performed
within the protocol specified timeframes they will be drawn at the time of the visit.

Inclusion Criteria:

To be considered eligible for enrollment, an individual must meet the criteria listed below
at the time of randomization:

NOTE: If the DXA scan is scheduled prior to randomization, all eligibility criteria must be
met prior to performing the DXA scan.

- Age 16 years and 0 days to 24 years and 364 days;

- Behaviorally infected with HIV (e.g., sexual contact, injection drug use; not infected
by perinatal transmission, blood transfusion, or at age younger than 9 years);

- HIV-1 infection as documented in subject's medical record by at least one of the
following criteria:

- reactive HIV screening test result with an antibody based FDA-licensed assay
followed by a positive supplemental assay (e.g., HIV-1 Western Blot, HIV-1
Indirect Immunofluorescence, Antibody Differentiation Assay (Multispot)); or

- positive HIV-1 DNA polymerase chain reaction (PCR) assay; or

- plasma HIV-1 quantitative RNA assay >1,000 copies/mL; or

- positive plasma HIV-1 RNA qualitative assay

- Subjects must have at least one documented HIV viral load that is below 200 copies/mL
collected following initiation of TDF containing cART and greater than 90 days prior
to randomization; no HIV viral load above 200 copies/mL if measured within the 90 days
prior to randomization; and an HIV viral load obtained at screening that is below 200
copies/mL.

- Currently being treated for at least 180 days by the time of randomization with a TDF
containing cART with at least 2 other FDA approved ARVs (NOTE: This may include a
TDF-containing fixed drug combination medication);

- Negative serum hepatitis B surface antigen (HBsAg) at screening or by history within 4
weeks prior to screening (see section 7.1.3);

- Willingness and ability to remain on the same cART regimen for the duration of study
participation;

- Willingness and ability to participate in the study, follow all study procedures for
the duration of study participation, and provide written informed consent or assent
with parental permission, if applicable; and

- For females of child-bearing potential, agreement to use a minimum of one
proven-effective method of birth control and willingness to postpone pregnancy for the
duration of study participation (see section 5.3.2 for permitted hormonal
contraceptives)

Exclusion Criteria:

To be considered eligible for enrollment, an individual must not meet any of the criteria
listed below at the time of randomization:

NOTE: If the DXA scan is scheduled prior to randomization, all eligibility criteria must be
met prior to performing the DXA scan.

- Prior hypersensitivity to vitamin D;

- History of sarcoidosis, arteriosclerosis, renal stones, glomerulonephritis,
interstitial kidney disease, nephrotic syndrome, hypercalcemia, osteoporosis and/or
other bone diseases, clinical diagnosis of hypoparathyroidism or hyperparathyroidism;

- Lactation or pregnancy currently or within the past 24 weeks;

- Chemotherapy or radiation therapy for malignancy within the past 12 months;

- Known presence of GI disease that, in the opinion of the clinician, would interfere
with study agent administration or absorption (e.g. Crohn's, Colitis);

- For subjects ≥ 18 years, confirmed creatinine clearance < 70 ml/min (estimated
glomerular filtration rate (GFR) from SCr using Cockcroft and Gault (CG) equation) and
for subjects <18 years, confirmed creatinine clearance < 70ml/min/1.73m2 (estimated
GFR from SCr using Schwartz formula (see section 3.5). (Estimated GFR may be
calculated using the formulae programmed on the ATN website);

- SCa > Upper Limit Normal (ULN) for local laboratory values (see section 7.1.3);

- Active Grade 3 or higher clinical or laboratory toxicity except atazanavir (ATV)
associated indirect hyperbilirubinemia (see section 9.5.2.2);

- Weight is > 350 pounds (lbs) or 159 kilograms (kgs);

- Positive hepatitis C antibody by history or at screening (see section 7.1.3); and

- Use of any medications as specified in sections 5.3.1, 5.3.3 and 5.4.

- Females Only: Use of certain hormonal contraceptives as specified in the protocol.
We found this trial at
17
sites
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
3400 N Charles St
Baltimore, Maryland 21205
410-516-8000
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
3550 Jerome Avenue
Bronx, New York 10467
(718) 920-4321
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
?
mi
from
Bronx, NY
Click here to add this to my saved trials
5050 Anthony Wayne Dr
Detroit, Michigan 48201
(313) 577-2424
Wayne State University Founded in 1868, Wayne State University is a nationally recognized metropolitan research...
?
mi
from
Detroit, MI
Click here to add this to my saved trials
1200 Moursund Street
Houston, Texas 77030
(713) 798-4951
Baylor College of Medicine Baylor College of Medicine in Houston, the only private medical school...
?
mi
from
Houston, TX
Click here to add this to my saved trials
262 Danny Thomas Pl
Memphis, Tennessee 38105
(901) 495-3300
St. Jude Children's Research Hospital St. Jude is unlike any other pediatric treatment and research...
?
mi
from
Memphis, TN
Click here to add this to my saved trials
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
4202 E Fowler Ave
Tampa, Florida 33620
(813) 974-2011
University of South Florida The University of South Florida is a high-impact, global research university...
?
mi
from
Tampa, FL
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
Chicago, Illinois 60612
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Los Angeles, California 90027
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
New Orleans, Louisiana 70112
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
?
mi
from
San Juan,
Click here to add this to my saved trials
111 Michigan Ave NW
Washington, District of Columbia
(202) 476-5000
Childrens National Medical Center As the nation’s children’s hospital, the mission of Children’s National Medical...
?
mi
from
Washington,
Click here to add this to my saved trials